Drug Type Recombinant protein |
Synonyms IL17-VAULT, VPI-131 |
Target |
Mechanism IL-17 agonists(IL-17 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | US | - |